Table 3. Experimental lines from (Barkoulas et al., 2013), and one line from (Hoyos et al., 2011), referred in this study.
Levels used to model the lines were based on measurements of EGF mRNA levels from (Barkoulas et al., 2013) or fit, as indicated. For combined perturbations, we indicate the corresponding single perturbations lines.
| EGF perturbation lines | |
|---|---|
| CB1417 |
lin-3(e1417) hypomorph; level included as fitting parameter ~0.28 × WT (measured as ~0.06 × WT in (Barkoulas et al., 2013) and ~0.22 × WT in [Saffer et al., 2011]) |
| JU2036 | measured as ~ 1.25 × WT |
| JU2035 | measured as ~ 1.79 × WT |
| JU1107 | measured as ~ 2.75 × WT |
| JU1100 (Hoyos et al., 2011) | level included as fitting parameter ~4.2 × WT (not measured) |
| Notch perturbation lines | |
| JU2039 | Pn.p cell-specific RNAi; level fit to phenotype strength ~0.4 × WT |
| JU2064 | ectopic Notch activity; level included as fitting parameter ~WT + 0.05 |
| JU2060 | ectopic Notch activity; level fit to yield near-complete P4/8.p conversion ~ WT + 0.26 |
| Combined perturbations | |
| JU2113 | JU2036 × JU2039 |
| JU2091 | JU2036 × JU2064 |
| JU2089 | JU2035 × JU2064 |
| JU2092 | JU1107 × JU2064 |
| JU2095 | CB1417 × JU2064 |